Month: April 2025

The power of patient advocacy is essential in improving health care navigation, patient-clinician dialogue, and the wider patient experience.  In the inherited (genetic) high cholesterol space, there is a gap in awareness and understanding of FH with the general public, most levels of health care, and with policymakers resulting in 90% of affected individuals remaining…

GPs have a critical role in assessing and helping their patients to reduce cardiovascular risk, including high cholesterol and FH, especially those who don’t yet have heart disease. It’s exciting that Medicare now rebates pathology companies for GP-requested “cascade” DNA testing for immediate relatives of people diagnosed with FH. Relatives of people diagnosed with FH…